Altamira Therapeutics (NASDAQ:CYTO) established a new business unit, OTC Consumer Health, to support the ongoing global roll out of Bentrio, its nasal spray for the protection against airborne viruses and allergens.
OTC Consumer Health will be led by Jean Lachance, who will join Altamira in May 2022. Mr. Lachance brings more than 20 years of global marketing and sales experience in over-the-counter (OTC) consumer health and pharmaceutical products. His experience spans multiple therapeutic areas and product categories, including the “cough & cold” and “allergy” categories, to which Bentrio belongs.
Mr. Lachance currently oversees global marketing initiatives for a variety of consumer care products at Abbott Established Product Division. Previously, he served as the senior regional marketing manager for Europe at Mundipharma Consumer Care; marketing director at Merck Consumer Care (now Bayer Consumer Care); allergy & cough cold brand manager at Schering-Plough; and sales, trade marketing & brand manager at Abbott Laboratories.
“With his extensive and demonstrable record of brand-building in international OTC markets, specifically in the allergy and cough & cold categories, Jean is exceptionally well qualified to help us maximize the global opportunity we see for Bentrio, which will drive strong growth in 2022 and beyond,” Thomas Meyer, founder, chairman and CEO of Altamira, said in a statement.
